Strategic Partnerships Primordial Genetics is pursuing a major strategic move through the Pelican merger with Ligand's portfolio to create a standalone synthetic biology company, signaling strong potential for partnerships or co development deals to scale enzyme and nucleic acid production platforms.

AI Driven Innovation Existing collaboration with an AI company to design better enzymes demonstrates openness to data driven, joint R&D models, presenting a pathway to partner with pharma, biotech startups, or CROs seeking accelerated enzyme engineering.

Nucleic Acid Production The focus on enzyme based production systems for RNA and DNA presents a clear sales angle to pharmaceutical and diagnostics companies needing reliable enzymes and scalable manufacturing workflows.

Sustainable Manufacturing A stated mission to shift away from fossil fuels toward a bio economy opens doors to sustainability minded manufacturers seeking greener bioprocess solutions, process development, and licensing of bio based production tech.

Protein Expression Platform FOMO-21 enables soluble expression of insoluble proteins in bacteria, providing a practical product for research labs and contract manufacturers; potential for licensing, distribution partnerships, or lab services to accelerate protein projects.